The epitopes of human thyroid-stimulating hormone (hTSH) recognized by two murine monoclonal antibodies (MAbs), designated MAb 279 and MAb 299, have been characterized. These MAbs are highly specific for the ,-subunit of TSH. The epitope recognized by MAb 279 appears to be completely conserved between bovine and human TSH and partially conserved in the porcine species. The TSH fl-subunit epitope recognized by MAb 299 is only partially conserved between the human, bovine and porcine species. Both MAbs are capable of inhibiting the binding of TSH to its receptor in a TSH radioreceptor assay, indicating that the epitopes either coincide or are located close to the TSH f-subunit receptor-binding sites. The
INTRODUCTION
Thyroid-stimulating hormone (TSH) is a member of the glycoprotein hormone (GPH) family which also includes follitropin (FSH), lutropin (LH) and chorionic gonadotropin (CG). These hormones are structurally related, with each GPH consisting of a common a-subunit which is non-covalently associated with a hormone-specific fl-subunit [1] . The three-dimensional structure of human CG (hCG) was very recently established by X-ray crystallography to 3 A resolution and molecular modelling studies indicate that the structures of the other GPHs may be essentially the same [2, 3] . Prior to the elucidation of the X-ray crystal structure of hCG, a variety of techniques have been employed to gain insight into the three-dimensional structure and epitopic topography of each of the GPHs. With respect to TSH, the relative spatial relationships of epitopes have been determined [4, 5] , the surface accessibility of particular sequence regions has been investigated using anti-peptide antibodies [6, 7] and the location of receptor-binding sites has been investigated using synthetic peptides [8, 9] . The TSH-receptor interaction has also been probed using monoclonal antibodies (MAbs) [10] [11] [12] and the involvement of the carbohydrates in the TSH f-subunit epitopes has been studied [13, 14] . However, no studies have yet identified regions or specific amino acid residues within the TSH ,f-subunit which comprise the epitopes for MAbs raised to the intact TSH or its subunits. Hence, this paper reports investigations into the binding and partial structural characteristics of the epitopes recognized by two TSH f-subunit-specific MAbs.
EXPERIMENTAL Hormone preparations
Bovine (b) TSH and LH were purified from bovine pituitary carbohydrate moieties of the TSH ,-subunit appear to play little or no role in the epitope recognition by MAb 279 or MAb 299 while the integrity of the disulphide bonds are essential. The epitopic recognition may also involve lysine residues, as determined by the immunoreactivity with both MAbs following citraconylation of TSH. In addition, the amino acid sequence region between residues bTSH 8344-4 could be excised by trypsin digestion of bovine TSH , (bTSHfl) without eliminating epitopic recognition by either MAb. These results provide further insight into the relationship between the structure of the TSH fl-subunit epitopes and location of the receptor-binding sites.
glands as described previously [15] . The bTSH a-and f-subunits were purified from this preparation by reverse-phase HPLC on a Bakerbond C18 column (25 cm x 0.46 cm i.d., 300 A pore size, 5 ,um particle diameter) (J. T. Baker, Phillipsburg, NJ, U.S.A.) using 0.1 % trifluoroacetic acid with elution performed with a linear 60 min gradient of 0-50 % acetonitrile. Residual a-subunit or intact hormone was then removed from the f-subunit preparations by gel-filtration chromatography on a Superdex 75 column (30 cm x 1 cm i.d.) (Pharmacia, Uppsala, Sweden) using NH4HCO3 as eluent. Crude bTSH (1 i.u./mg) and porcine TSH (pTSH) (5 i.u./mg) were purchased from Sigma Chem. Co. (St. Louis, MO, U.S.A.). The human TSH (hTSH) was obtained from the Human Pituitary Advisory Committee (Canberra, Australia), recombinant hFSH was kindly donated by Dr. Peter Schofield of the Garvan Institute of Medical Research (Darlinghurst, NSW, Australia), hCG (4723 i.u./mg) was purchased from Calbiochem Corp. (La Jolla, CA, U.S.A.). The concentration of each protein tested in the various assays or used for modification was determined by amino acid analysis using the Picotag method (Millipore) [16] performed as described previously [17] . Bovine TSH was iodinated to a specific radioactivity of 30 mCi/mg using a modification of the lactoperoxidase (EC 1.11.1.7) method [18] then affinity purified with bTSH receptors as described previously [19] . Bovine TSH/i was similarly iodinated to a specific radioactivity of 62 mCi/mg.
Monoclonal antibodies

lodination of MAbs
Protein-A affinity-purified preparations of MAb 279 and MAb 299 were iodinated to an average specific radioactivity of 32-42 mCi/mg using the 'lodobead' method (Pierce, Rockford, IL, U.S.A.). Briefly, each MAb (5 ,ug) was diluted in a total volume of 100 ,1 of 100 mM potassium phosphate buffer, pH 7.0, and one iodobead added. The iodination was initiated by the addition of 0.5 mCi (5 ,u) of Na125I (Amersham, Bucks., U.K.). Following incubation at room temperature for 15 min with continuous mixing, the reaction mixture was applied to a Sephadex G-25 (fine) (Pharmacia) column (4 cm x 0.8 cm i.d.) pre-equilibrated in phosphate-buffered saline (PBS) to remove unbound radio-iodide. The radiolabelled protein fraction was then stored at 4°C for use in the immunoradiometric assay.
Enzyme-linked immunosorbent assay (ELISA)
The proteins were diluted in 40 mM NaHCO3/Na2CO3, pH 9. Citraconylation of bTSH Citraconylation of native bTSH was achieved using a modification of the method of Atassi and Habeeb [21] . Bovine TSH (290 ,ug) was dissolved in 200 ,ul of 0.1 M Na4P207, pH 9.0, and a total 60-fold molar excess (based on the lysine content of bTSH) was added as eight 5 ,1 aliquots of citraconic anhydride (Sigma Chem. Co.) (diluted 1:4 in 100 % ethanol) 30 min apart.
The pH was checked after each addition of citraconic anhydride and maintained at approx. pH 8.5 by the addition of 5 M NaOH. The mixture was incubated for a further 2 h at room temperature then centrifuged in a microfuge for 3 min. The supernatant was then applied to a column (4 cm x 0.8 cm i.d.) of Sephadex G-25, pre-equilibrated with 100 mM NH4HCO3 and the protein fraction collected and stored at -20 'C. A sample (approx. 10 % of total) was deblocked by incubation in 8 vol. of 0.1 % (v/v) trifluoroacetic acid for 4.5 h at room temperature. The deblocked sample was then lyophilized and resuspended in 100 mM NH4HCO3 and stored at -20 'C.
Trypsin digestion of bTSHp8 Bovine TSH,8 (12 ,ug) (w/w)] dissolved in 10 ,1 of 1 mM HC1 was added. Digestion was allowed to proceed for 20 h at room temperature with constant mixing, and aliquots (2.5 ,ug and 1 ,ug) were removed for testing in the TSH-RIA and SDS/PAGE (reduced and non-reduced) respectively. In each case, tryptic digestion was stopped by the addition of soybean trypsin inhibitor (STI; Boehringer Mannheim) [STI: trypsin ratio was 2: 1 (w/w)] in 10 ,ul of 100 mM NH4HCO3. The remaining sample was lyophilized, resuspended in 1001ul of 0.1 % (v/v) trifluoroacetic acid and applied directly to a polybrene-treated glass-fibre disc which was placed in an Applied Biosystems gas-phase protein sequencer (model 470A) and sequenced for three cycles to determine the location of the trypsin cleavage sites in the bTSH,# sequence.
SOS/PAGE analysis
Proteins were separated on 12.5 % polyacrylamide gels under non-reducing and reducing conditions with a stacking gel of 5 % polyacrylamide according to the method of Laemmli [22] , and were silver-stained using the Wray procedure [23] . Samples were diluted in sample buffer and incubated at 100 'C for 3 min before loading on to the gel. The reduced samples were prepared by boiling in sample buffer containing 28 mg/ml dithiothreitol. Electrophoresis was performed overnight with a constant current of 7.5 mA. (raised against hLH) was included as a negative control. The saturability of the receptors by bTSH in the radio-receptor assay is also shown. Reductive alkylation (with iodoacetic acid or iodoacetamide) of bTSH was used to determine whether the epitopes for MAb 279 and MAb 299 were dependent on the native conformation of the hormone. SDS/PAGE under non-reducing conditions of the reduced and alkylated preparations indicated that both subunits were fully reduced (data not shown). The immunoreactivity of the fully reduced and alkylated bTSH preparations for both MAbs was completely abolished in the ELISA (data not shown) indicating that the epitopes recognized by MAb 279 and MAb 299 are dependent on the disulphide bonds of the bTSH ,-subunit being intact.
RESULTS
antibodies to provide a more detailed analysis of the relative locations of the epitopes. When MAb 279 was used as the detection antibody, it was able to bind to hTSH which was prebound to MAb 299, indicating that these two MAbs recognize distinct epitopes (Table 2) The yields (pmol) of amino acids following three cycles of N-terminal sequencing of trypsin-digested bTSH,3 are shown with the bold numbers referring to the yields of the amino acid residues which are either located at the N-terminus of bTSH/3 or constitute the peptides formed by trypsin digestion (see Table 4 ). Table 4 Deduced major trypsin cleavage sites of bTSHf0
The yields of the N-terminal sequence of bTSH,8, Phel-Cys2-lle3, were used as a guide to the total amount of sequenceable tryptic fragments expected on each Edman cycle. As more than one fragment sequence may contain the same amino acid residue at a particular sequencing cycle, comparison of the yields obtained on each cycle with those of the N-terminal sequence enabled the identification of such an occurrence. For example, the yield of 174 pmol of valine on cycle 2 (Table 3 ) was approximately double the yield of Phe1 on cycle 1, hence two fragments must contain a valine at position 2, therefore 50% yield was arbitrarily assigned to each sequence. PT-10b, (Figure 2, lane 1) . This decrease in molecular mass indicates that either a portion(s) of the subunit was cleaved following digestion and/or that significant changes in the hydrodynamic shape of the digested protein had occurred. The reduced, digested TSH /-subunit migrated in SDS/PAGE with the dye-front (Figure 2, lane 5) , indicating that fragments of less than 11 700 Da were formed and further emphasizing that complete digestion occurred.
Characterization of the trypsin-digested bTSH f8-subiinit
The cleavage sites of the trypsin-digested bTSH /8-subunit were characterized by N-terminal sequencing of the unseparated cleavage products. These results are summarized in Tables 3 and   4 . The yields of the N-terminal sequence (Phel-Cys2-lle3) were used as a guide to determine the amount of each fragment sequenced at each automated Edman cycle. Comparison of these sequencing results with the known primary structure and tryptic cleavage sites of the reduced and alkylated bTSH (Figure 3 enabled the identification of these sites in the present study. Using this approach, the following preferred trypsin cleavage sites of the native bTSH f-subunit were determined: namely between the residues /334-35, /339-40, ,/44-45 and /369-70. The peptides /35-39 and ,/40-44 were completely excised from the /,-subunit following trypsin digestion, as both of these peptides lack half-cystine residues.
DISCUSSION
Although previous studies have extensively characterized the epitopes recognized by MAbs raised against hCG, LH and FSH, there are very few reports of the characterization of epitopes recognized by anti-TSH MAbs. In this present investigation, the structures of the epitopes on the TSH /3-subunit recognized by two murine anti-TSH MAbs, designated MAb 279 and MAb 299, have been partially characterized. The affinities of these MAbs for the various intact GPHs and free subunits (Table 1) indicate a number of similarities as well as differences in their epitope specificities. Both antibodies were highly specific for TSH, with neither MAb cross-reacting with any of the other GPHs tested. This result is consistent with the /3-subunits for each of the GPHs possessing unique amino acid sequences. However, it has previously been demonstrated that MAbs specific for two (out of a total of six) distinct epitopes on hTSH,/ epitopes can also recognize other GPHs [4] . The inability of MAb 279 and MAb 299 to bind to the other GPHs indicates that the epitopes for these MAbs are unique to TSH and hence potentially involve amino acid sequence regions which confer TSH hormonal specificity and which are of low sequence similarity with the other GPH /3-subunits. The results also indicate that both epitopes are conformational (as opposed to contiguous) in nature, as they are dependent on the disulphide bridges being intact to maintain their structures. Other studies have also previously demonstrated that the hTSH epitopes are dependent on the disulphide bond structure [5] .
Various studies have revealed that the carbohydrate moieties can play a role in the immunogenicity of the GPHs [13, 14, 24, 25] . In particular, studies with enzymically deglycosylated hTSH [13, 14] have indicated that the majority of the glycosylationdependent epitopes are located on the /-subunit. In the present study, removal of the carbohydrate moieties from both subunits of bTSH by chemical deglycosylation resulted in an approximate 2-fold decrease in the affinity of both MAb 279 and MAb 299 compared with the fully glycosylated bTSH (Table 1) . This result, however, most probably reflects an overall alteration in the hormone conformation rather than direct involvement of the carbohydrates in the epitopes as suggested by Schwarz et al. [26] for hCG. The specificities of MAb 279 and MAb 299 are therefore likely to be different to those investigated by Papandreou et al. [13] . Other studies with both enzymically deglycosylated hTSH [5] and hCG [26] [30] and equine CG [31] . Whichever explanation is the case, the differential binding of MAb 279 and MAb 299 to hTSH when other MAbs were employed in the IRMA as capture MAbs, further emphasizes their distinct epitope specificities (Table 2) .
MAbs 279 and 299 were both able to inhibit the interaction of radio-iodinated bTSH with its receptor in a dose-dependent manner ( Figure 1 ). Similar observations have been made in other studies in which MAbs to TSH [10, 11] and other GPHs (e.g. [31] [32] [33] Trypsin digestion of the native bTSH /3-subunit and characterization of the products were performed to enable elucidation of the potential lysine and arginine residues which may be involved in the epitopes recognized by MAb 279 and MAb 299. Excision of the sequence region between bTSH/335-44 was evident following N-terminal sequencing of the trypsindigested bTSH /3-subunit (Tables 3 and 4) . A proteolytic clip was also introduced into the hormone between /3Arg69-His70. These results represent to our knowledge the first report on the fragmentation sites leading to the tryptic-core of TSH, and are comparable with other data obtained for the tryptic-core fragment of hCG [36] (Figure 3 ). The cleavage observed at bTSH/334-35 (i.e. at the sequence position analogous to hCG/341-42 upon alignment of the sequences of the hCG/3 and TSH/3 subunits) is very close to the hCG/343-44 trypsin cleavage site. Proteolytic cleavage at Arg43 in hCG,/ by endoproteinase-Arg C has also been observed previously [37] . Similarly, the bTSH/369-70 cleavage site determined in the present investigation is directly analogous to the hCGp374-75 trypsin cleavage site. Due to the presence of the six disulphide bonds, no peptides can be released from hCG following trypsin digestion (except the C-terminal extension peptide hCG/3l 14-145 which is not present in TSH), while with TSH/3 the region between Asp35-Lys44 can clearly be excised. This difference is readily explained by the fact that there is not an additional trypsin cleavage site in the analogous region of hCG,/ (Figure 3) . In summary, these results support the conclusion that the regions between /331-52 in TSH and /38-57 in hCG are surface exposed, consistent with the proposal that this region constitutes a receptor-binding domain for the GPHs [8, 38, 39] . The X-ray crystallographic structure of hCG [2, 3] indicates that this region forms a large, outwardly projecting loop structure with the cleavage sites analogous to TSH ,/ [34] [35] and /339-40 buried at the a//,-subunit interface in the intact hormone, while the /44-45 cleavage site is exposed to the solvent. In the free /3-subunit, however, all of these cleavage sites are likely to be exposed to the solvent as the above results dem- [8, 9] , are probably more relevant candidates as sequence regions contributing to the epitopes recognized by MAb 279 and MAb 299. Studies using anti-peptide antibodies raised to the C-terminus of hTSH/3 [6, 7] have indicated that the Cterminal region (i.e. /395-112) of hTSH is antibody-accessible in both the intact hormone and the free subunit, while conflicting results have been obtained for antibodies to peptides from the Nterminal region (i.e. /31-15) [6, 7] . Anti-peptide antibodies raised against a peptide encompassing the sequence /353-76 have also been shown to be capable of binding to the TSH /3-subunit and the native intact hormone [7] .
In summary, the epitopes recognized by 
